Previous Close | 27.59 |
Open | 27.71 |
Bid | 0.00 x 3100 |
Ask | 27.82 x 2900 |
Day's Range | 27.54 - 27.93 |
52 Week Range | 25.61 - 42.22 |
Volume | |
Avg. Volume | 43,665,659 |
Market Cap | 157.305B |
Beta (5Y Monthly) | 0.56 |
PE Ratio (TTM) | 75.08 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 1.68 (6.05%) |
Ex-Dividend Date | Jan 25, 2024 |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for PFE
Pfizer stock remains under pressure despite becoming one of the biggest names of the pandemic. Is PFE stock a sell?
Data from a late-stage study shows that Moderna's (MRNA) next-generation COVID vaccine induces a more robust immune response compared with its previously approved bivalent COVID vaccine.
Let’s talk about stock picking. It’s a bit like going to an orchard: if you get there too late, the low-hanging fruit is all gone, and you’ll have to work harder to find the best pieces. Orcharders have ladders and pruning hooks to make the job easier; retail investors can turn to the Smart Score. The Smart Score uses a combination of AI and natural language processing, through an algorithm by TipRanks, to gather and collate the mountain of raw data tossed up by the regular daily activity of the